C

Calithera Biosciences Inc
F:2CB

Watchlist Manager
Calithera Biosciences Inc
F:2CB
Watchlist
Price: 3.86 EUR -2.53% Market Closed
Market Cap: 1m EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

2CB Price Targets Summary
Calithera Biosciences Inc

There are no price targets for 2CB.
2CB Lowest Forecast
Wall Street Target
Not Available
2CB Average Forecast
Wall Street Target
Not Available
2CB Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Calithera Biosciences Inc Competitors:
Price Targets
LEGN
Legend Biotech Corp
79% Upside
HUMA
Humacyte Inc
296% Upside
C
2487
Cutia Therapeutics
4% Downside
CPRX
Catalyst Pharmaceuticals Inc
65% Upside
LEGN
Legend Biotech Corp
79% Upside
HUMA
Humacyte Inc
296% Upside
C
2487
Cutia Therapeutics
4% Downside
CPRX
Catalyst Pharmaceuticals Inc
65% Upside
TNG
Transgene SA
104% Upside
ELUT
Elutia Inc
298% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
1% Downside
BIIB
Biogen Inc
32% Upside

Revenue
Forecast

Revenue Estimate
Calithera Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Calithera Biosciences Inc

Operating Income forecast
is not available for
Calithera Biosciences Inc

Net Income
Forecast

Net Income Estimate
Calithera Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
2CB intrinsic value, competitors valuation, and company profile.
DCF Valuation
2CB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2CB stock valuation using valuation multiples.
Wall Street Estimates
2CB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2CB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2CB's stock price target?
Not Available

2CB doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 270,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.